CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors
April 15, 2024 16:05 ET
|
Cargo Therapeutics, Inc.
SAN MATEO, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (Nasdaq: CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell...
CARGO Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 21, 2024 16:05 ET
|
Cargo Therapeutics, Inc.
CARGO Therapeutics today provided a business update and reported financial results for the quarter and year ending December 31, 2023.
CAR-T Funding Report 2024: Venture Capital, IPOs, Licensing Deals, Collaborations, and M&A Transactions
March 18, 2024 04:52 ET
|
Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "CAR-T Funding Report - Venture Capital, IPOs, Licensing Deals, Collaborations, and M&A Transactions, 2024" report has been added to ...
CARGO Therapeutics to Participate in the 44th Annual Cowen Healthcare Conference
February 29, 2024 16:01 ET
|
Cargo Therapeutics, Inc.
CARGO Therapeutics announced that the company will participate in the 44th Annual Cowen Healthcare Conference, taking place March 4-6, 2024, in Boston, MA.
CARGO Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024 08:05 ET
|
Cargo Therapeutics, Inc.
SAN MATEO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ: CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell...
CARGO Therapeutics Reports Business Updates and Third Quarter 2023 Results
December 13, 2023 16:05 ET
|
Cargo Therapeutics, Inc.
SAN MATEO, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (Nasdaq: CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell...
CARGO Therapeutics Announces Scientific Advisory Board
December 06, 2023 08:05 ET
|
Cargo Therapeutics, Inc.
SAN MATEO, Calif., Dec. 06, 2023 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (CRGX), a clinical-stage biotechnology company uniquely positioned to advance next generation, potentially curative cell...
CARGO Therapeutics Announces Appointment of Ginna Laport, MD, as Chief Medical Officer
October 17, 2023 09:05 ET
|
CARGO Therapeutics, Inc.
— Accomplished clinical leader with significant expertise in hematology/oncology drug development and a track record of advancing multiple modalities of cancer therapeutics — SAN MATEO, Calif., Oct. ...
CARGO Therapeutics Announces Appointment of Michael Ports, PhD, as Chief Scientific Officer
September 12, 2023 09:05 ET
|
CARGO Therapeutics, Inc.
– Scientific leader with multi-company cell therapy drug development experience spanning early discovery initiatives through late-stage development – SAN MATEO, Calif., Sept. 12, 2023 (GLOBE...
CARGO Therapeutics Appoints Biotech Life Sciences Leaders to Board of Directors
August 24, 2023 09:05 ET
|
CARGO Therapeutics, Inc.
– Board of Director appointments follow the Company’s recent launch and $200 million Series A financing in March 2023 – – Appointments include industry veterans John Orwin as Chairman, David Lubner...